fluoxetine and carbamazepine

fluoxetine has been researched along with carbamazepine in 91 studies

Research

Studies (91)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's20 (21.98)18.2507
2000's18 (19.78)29.6817
2010's48 (52.75)24.3611
2020's5 (5.49)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H1
Bhat, MA; Ehtaishamul Haque, S; Khan, SA; Rana, A; Siddiqui, N1
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J1
Bleich, S; Kornhuber, J; Rupprecht, R; Terfloth, L; Wiltfang, J1
Ahman, M; Holmén, AG; Wan, H1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Glen, RC; Lowe, R; Mitchell, JB1
Ekins, S; Williams, AJ; Xu, JJ1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F1
Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ1
Sen, S; Sinha, N1
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Gernaat, HB; Touw, DJ; van der Woude, J1
Alarcon, RD; Johnson, BR; Lucas, JP1
Carter, JG; D'Mello, AP; D'Souza, MJ; Grimsley, SR; Jann, MW1
Gernaat, HB; Touw, DJ; Van de Woude, J1
Feder, R1
Pearson, HJ1
Bushnell, DL; Hines, ME; Manshadi, FF; Roberts, MA1
Campbell, M; Cueva, JE1
Leitner, P; Serfling, R1
Dursun, SM; Mathew, VM; Reveley, MA1
Reus, VI1
Anderson, GD; Gidal, BE; Miyoshi, HR; Seaton, TL; Wilenksy, AJ1
Avenoso, A; Caputi, AP; Fazio, A; Pisani, F; Pollicino, AM; Spina, E1
Asnis, J; Patel, SV; Tariot, PN1
Daniel, WA; Wójcikowski, J2
Brent, NB; Wisner, KL1
Boerlin, HL; Gitlin, MJ; Hammen, CL; Zoellner, LA1
Dailey, JW; Jobe, PC; Milbrandt, JC; Reith, ME; Steidley, KR1
Björnsdóttir, I; Einarson, A; Einarson, TR; Gerichhausen, S; Koren, G; Lyszkiewicz, DA1
Jiang, A; LoGrasso, PV; Stearns, BA; Trauger, JW1
Bocchetta, A; Del Zompo, M; Martinelli, V; Palmas, AM1
De Lange, HJ; Lürling, M; Murk, AJ; Noordoven, W; Peeters, ET1
André, C; Blaise, C; Gagné, F; Salazar, M1
Borowicz, KK; Czuczwar, SJ; Furmanek-Karwowska, K; Luszczki, JJ; Sawicka, K1
DeLorenzo, ME; Fleming, J1
Preskorn, SH1
Ketter, TA1
Ames, A; Czajkowski, KP; Fang, M; Spongberg, AL; Witter, JD; Wu, C1
Marilov, VV; Sologub, MB1
Ford, AT; Guler, Y1
Halden, RU; McClellan, K; Walters, E1
Castberg, I; Davies, SJ; Lennard, MS; Lewis, G; Spigset, O; Taylor, S; Westin, AA1
Luong, D; Metcalfe, CD; Oakes, KD; Pawliszyn, J; Servos, MR; Wen, JZ; Zhang, X1
Chambers, CD1
Joshi, PP; Klaper, RD; Thomas, MA1
Bragg, L; Cui, S; Dixon, DG; Liu, H; Oakes, KD; Ouyang, G; Pawliszyn, J; Servos, MR; Wang, S1
Bragg, LM; Dixon, G; Oakes, KD; Pawliszyn, J; Servos, MR; Wang, S1
Oakes, KD; Pawliszyn, J; Servos, MR; Togunde, OP1
Klaper, RD; Thomas, MA1
Li, B; Yu, K; Zhang, T1
Coleman, HM; Khan, SJ; Le-Clech, P; Stuetz, RM; Trinh, T; van den Akker, B1
Arora, T; Bhowmik, M; Khanam, R; Vohora, D1
Braitberg, G; Fisher, J; Graudins, A; Taori, G1
Bergström, E; Boxall, AB; Carter, LJ; Dowle, A; Garman, CD; Ryan, J; Thomas-Oates, J1
Cardoso, DN; Loureiro, S; Oliveira, M; Soares, AM1
Prosser, RS; Sibley, PK; Trapp, S1
Baudot, R; Berlioz-Barbier, A; Buleté, A; Cren-Olivé, C; Garric, J; Gust, M; Wiest, L1
Askenazy, F; Dor, E; Fernandez, A; Menard, ML; Thümmler, S1
Gold, PW; Goldstein, SA; Kling, MA; Licinio, J; Michelson, D; Mouro, CM; Pavlatou, MG; Wong, ML1
Barata, C; Campos, B; Rivetti, C1
Batley, GE; Hutchinson, TH; Kumar, A; Nidumolu, B1
Boxall, ABA; Carter, LJ; Ryan, JJ1
Aho, K; Bearden, S; Finney, B; Huber, DP; Kaushik, G; Thomas, MA; Zarbalis, KS1
Kaushik, G; Thomas, MA; Xia, Y; Yang, L1
Benskin, JP; Butler, H; Chandramouli, B; Cosgrove, JR; Helbing, CC; Huang, SSY; Veldhoen, N1
Kaushik, G; Pfau, JC; Thomas, MA; Xia, Y1
Lourenço, J; Mendo, S; Ofoegbu, PU; Pestana, JLT; Soares, AMVM1
Ajaman, M; Ghorbanzadeh, B; Naserzadeh, R1
Cardoso, DN; Loureiro, S; Oliveira, M; Soares, AMVM1
Kenda, M; Sollner Dolenc, M; Zore, T1
Chen, KY; Li, RY1
Doucette, WJ; Lombardero, LR; Pérez, DJ1

Reviews

6 review(s) available for fluoxetine and carbamazepine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1995, Volume: 34, Issue:10

    Topics: Adolescent; Alprazolam; Anticonvulsants; Antipsychotic Agents; Anxiety, Separation; Bipolar Disorder; Carbamazepine; Child; Child Behavior Disorders; Child, Preschool; Clonidine; Clozapine; Depressive Disorder; Dose-Response Relationship, Drug; Feeding and Eating Disorders; Fluoxetine; Humans; Imipramine; Lithium; Mutism; Obsessive-Compulsive Disorder; Phenobarbital; Phenytoin; Phobic Disorders; Schizophrenia; Sleep Wake Disorders; Tranquilizing Agents

1995
[The value of psychopharmacotherapy in the treatment of borderline personality disorder].
    Psychiatrische Praxis, 1993, Volume: 20, Issue:6

    Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Borderline Personality Disorder; Carbamazepine; Fluoxetine; Humans; Psychotropic Drugs

1993
Rational polypharmacy in the treatment of mood disorders.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1993, Volume: 5, Issue:2

    Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Thyroid Hormones; Tryptophan

1993
Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    The Journal of clinical psychiatry, 2008, Volume: 69 Suppl 5

    Topics: Acute Disease; Affect; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Lithium Carbonate; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Treatment Outcome; United States; United States Food and Drug Administration; Valproic Acid

2008
Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review.
    PloS one, 2022, Volume: 17, Issue:10

    Topics: Amitriptyline; Anticonvulsants; Antidepressive Agents; Carbamazepine; Duloxetine Hydrochloride; Fluoxetine; Gabapentin; Humans; Lamotrigine; Multicenter Studies as Topic; Network Meta-Analysis; Neuralgia; Pregabalin; Randomized Controlled Trials as Topic; Vitamins

2022

Trials

3 trial(s) available for fluoxetine and carbamazepine

ArticleYear
Carbamazepine coadministration with fluoxetine or fluvoxamine.
    Therapeutic drug monitoring, 1993, Volume: 15, Issue:3

    Topics: Adult; Carbamazepine; Depression; Drug Interactions; Drug Therapy, Combination; Epilepsy, Complex Partial; Epilepsy, Tonic-Clonic; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged

1993
Bipolar depression and antidepressant-induced mania: a naturalistic study.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:7

    Topics: Adult; Ambulatory Care; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Lithium; Male; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Verapamil

1998
[Comparative effectiveness of mood stabilizers in the complex therapy of bulimia nervosa].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:1

    Topics: Affect; Antidepressive Agents, Second-Generation; Antimanic Agents; Bulimia Nervosa; Carbamazepine; Cognition; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Lamotrigine; Treatment Outcome; Triazines; Young Adult

2010

Other Studies

82 other study(ies) available for fluoxetine and carbamazepine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:3

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations

2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
    Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19

    Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats

2007
N-{[(6-substituted-1,3-benzothiazole-2-yl)amino]carbonothioyl}-2/4-substituted benzamides: synthesis and pharmacological evaluation.
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:5

    Topics: Animals; Anticonvulsants; Benzamides; Benzothiazoles; Central Nervous System Depressants; Chemical and Drug Induced Liver Injury; Liver Function Tests; Male; Mice; Rats; Rats, Wistar; Seizures; Structure-Activity Relationship; Sulfides

2008
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
    Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2

    Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase

2008
Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:6

    Topics: Binding Sites; Computer Simulation; Databases, Factual; Models, Chemical; Models, Molecular; Molecular Structure; Molecular Weight; Psychotropic Drugs; Serotonin 5-HT3 Receptor Antagonists; Structure-Activity Relationship

2009
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
    Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6

    Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2

    Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution

2011
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3

    Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results

2011
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:2

    Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship

2011
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7

    Topics: Glutathione; Pharmacology; Sulfur Radioisotopes

2011
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1

    Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
[Parkinsonism following addition of fluoxetine to the treatment with neuroleptics or carbamazepine].
    Nederlands tijdschrift voor geneeskunde, 1992, Feb-15, Volume: 136, Issue:7

    Topics: Adult; Aged; Antipsychotic Agents; Carbamazepine; Dopamine Antagonists; Drug Interactions; Female; Fluoxetine; Humans; Male; Parkinson Disease, Secondary; Serotonin Antagonists

1992
Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1991, Volume: 30, Issue:6

    Topics: Adolescent; Aggression; Carbamazepine; Child; Clomipramine; Dose-Response Relationship, Drug; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Paranoid Disorders

1991
Increased carbamazepine plasma concentrations after fluoxetine coadministration.
    Clinical pharmacology and therapeutics, 1991, Volume: 50, Issue:1

    Topics: Administration, Oral; Adult; Carbamazepine; Chromatography, High Pressure Liquid; Drug Interactions; Fluoxetine; Humans; Male

1991
Fluoxetine and parkinsonism in patients taking carbamazepine.
    The American journal of psychiatry, 1991, Volume: 148, Issue:11

    Topics: Aged; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Psychotic Disorders; Serotonin

1991
Fluoxetine-induced mania.
    The Journal of clinical psychiatry, 1990, Volume: 51, Issue:12

    Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium

1990
Interaction of fluoxetine with carbamazepine.
    The Journal of clinical psychiatry, 1990, Volume: 51, Issue:3

    Topics: Carbamazepine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged

1990
Neurobehavioural dysfunction following mild traumatic brain injury in childhood: a case report with positive findings on positron emission tomography (PET).
    Brain injury, 1995, Volume: 9, Issue:5

    Topics: Accidents, Traffic; Anticonvulsants; Antidepressive Agents, Second-Generation; Brain Concussion; Brain Damage, Chronic; Carbamazepine; Child; Child Behavior Disorders; Electroencephalography; Energy Metabolism; Epilepsy, Post-Traumatic; Fluoxetine; Follow-Up Studies; Humans; Male; Mental Recall; Neurocognitive Disorders; Neuropsychological Tests; Temporal Lobe; Tomography, Emission-Computed; Vasodilator Agents; Verapamil; Whiplash Injuries

1995
Toxic serotonin syndrome after fluoxetine plus carbamazepine.
    Lancet (London, England), 1993, Aug-14, Volume: 342, Issue:8868

    Topics: Carbamazepine; Drug Interactions; Female; Fluoxetine; Humans; Serotonin; Syndrome

1993
Evaluation of the effect of fluoxetine on the formation of carbamazepine epoxide.
    Therapeutic drug monitoring, 1993, Volume: 15, Issue:5

    Topics: Animals; Carbamazepine; Drug Evaluation, Preclinical; Drug Interactions; Fluoxetine; Humans; In Vitro Techniques; Liver; Male; Microsomes, Liver; Perfusion; Rats; Rats, Sprague-Dawley

1993
L-Deprenyl augmentation of fluoxetine in a patient with Huntington's disease.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1996, Volume: 8, Issue:1

    Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Attention; Carbamazepine; Depression; Drug Interactions; Drug Therapy, Combination; Expressed Emotion; Female; Fluoxetine; Humans; Huntington Disease; Impulsive Behavior; Monoamine Oxidase Inhibitors; Movement; Selegiline; Violence

1996
Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs.
    Pharmacology & toxicology, 1997, Volume: 80, Issue:2

    Topics: 1-Naphthylamine; Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents, Tricyclic; Carbamazepine; Drug Interactions; Fluoxetine; Imipramine; Lysosomes; Male; Monensin; Phospholipids; Promazine; Psychotropic Drugs; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Tissue Distribution

1997
Interactions between promazine and antidepressants at the level of cellular distribution.
    Pharmacology & toxicology, 1997, Volume: 81, Issue:6

    Topics: 1-Naphthylamine; Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Fluoxetine; Hydrogen-Ion Concentration; Imipramine; Lysosomes; Male; Promazine; Rats; Rats, Wistar; Sertraline

1997
Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair.
    Clinical pediatrics, 1998, Volume: 37, Issue:1

    Topics: Adult; Anticonvulsants; Bipolar Disorder; Breast Feeding; Carbamazepine; Female; Fluoxetine; Humans; Infant, Newborn; Milk, Human; Pregnancy; Pregnancy Complications

1998
Carbamazepine-induced release of serotonin from rat hippocampus in vitro.
    Epilepsia, 1998, Volume: 39, Issue:10

    Topics: Animals; Anticonvulsants; Carbamazepine; Carrier Proteins; Citalopram; Fluoxetine; Hippocampus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Synaptosomes

1998
Evidence based information on drug use during pregnancy: a survey of community pharmacists in three countries.
    Pharmacy world & science : PWS, 2001, Volume: 23, Issue:2

    Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antitrichomonal Agents; Canada; Carbamazepine; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Fluoxetine; Humans; Iceland; Metronidazole; Netherlands; Patient Education as Topic; Pharmacies; Pharmacists; Pregnancy

2001
Drug interactions with selective serotonin reuptake inhibitors, especially with other psychotropics.
    Prescrire international, 2001, Volume: 10, Issue:51

    Topics: Anticoagulants; Anticonvulsants; Antidepressive Agents, Second-Generation; Carbamazepine; Contraindications; Drug Interactions; Fluoxetine; Humans; Monoamine Oxidase Inhibitors; Phenytoin; Selective Serotonin Reuptake Inhibitors

2001
Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2).
    Biochemistry, 2002, Nov-12, Volume: 41, Issue:45

    Topics: 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific); 3-Hydroxysteroid Dehydrogenases; 5-alpha-Dihydroprogesterone; Carbamazepine; Catalysis; Clozapine; Enzyme Activation; Enzyme Inhibitors; Fluoxetine; Flurbiprofen; Humans; Hydroxysteroid Dehydrogenases; Kinetics; Oxidation-Reduction; Pregnanediones; Pregnanolone; Recombinant Fusion Proteins; Selective Serotonin Reuptake Inhibitors; Substrate Specificity; Ursodeoxycholic Acid

2002
An interaction between carbamazepine and fluvoxamine.
    British journal of clinical pharmacology, 1993, Volume: 36, Issue:6

    Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Carbamazepine; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Humans; Middle Aged

1993
Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations of pharmaceuticals.
    Aquatic toxicology (Amsterdam, Netherlands), 2006, Jun-30, Volume: 78, Issue:3

    Topics: Amphipoda; Analgesics, Non-Narcotic; Animals; Anticonvulsants; Antidepressive Agents, Second-Generation; Behavior, Animal; Carbamazepine; Cetrimonium; Cetrimonium Compounds; Dose-Response Relationship, Drug; Environmental Monitoring; Fluoxetine; Fresh Water; Ibuprofen; Lethal Dose 50; Motor Activity; Surface-Active Agents; Water Pollutants, Chemical

2006
Effects of pharmaceutical products and municipal wastewaters on temperature-dependent mitochondrial electron transport activity in Elliptio complanata mussels.
    Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2006, Volume: 143, Issue:4

    Topics: Bivalvia; Caffeine; Carbamazepine; Cholestanol; Cotinine; Electron Transport; Fluoxetine; Ibuprofen; Lipid Peroxidation; Mitochondria; Novobiocin; Pharmaceutical Preparations; Sewage; Temperature; Trimethoprim; Xenobiotics

2006
Chronically administered fluoxetine enhances the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model.
    European journal of pharmacology, 2007, Jul-12, Volume: 567, Issue:1-2

    Topics: Animals; Anticonvulsants; Avoidance Learning; Brain; Carbamazepine; Drug Interactions; Drug Synergism; Electroshock; Fluoxetine; Male; Memory; Mice; Motor Activity; Phenobarbital; Phenytoin; Seizures; Selective Serotonin Reuptake Inhibitors; Valproic Acid

2007
Individual and mixture effects of selected pharmaceuticals and personal care products on the marine phytoplankton species Dunaliella tertiolecta.
    Archives of environmental contamination and toxicology, 2008, Volume: 54, Issue:2

    Topics: Carbamazepine; Chlorophyta; Clofibric Acid; Diclofenac; Drug Interactions; Fluoxetine; Household Products; Phytoplankton; Simvastatin; Triclosan; Water Pollutants, Chemical

2008
Deconstructing a medication regimen.
    Journal of psychiatric practice, 2008, Volume: 14, Issue:2

    Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Benztropine; Biotransformation; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium Carbonate; Metabolic Clearance Rate; Ranitidine; Risperidone; Stupor; Valproic Acid

2008
Dissipation and leaching potential of selected pharmaceutically active compounds in soils amended with biosolids.
    Archives of environmental contamination and toxicology, 2010, Volume: 59, Issue:3

    Topics: Carbamazepine; Clindamycin; Diltiazem; Diphenhydramine; Environmental Restoration and Remediation; Fluoxetine; Pharmaceutical Preparations; Sewage; Soil Pollutants

2010
Anti-depressants make amphipods see the light.
    Aquatic toxicology (Amsterdam, Netherlands), 2010, Sep-01, Volume: 99, Issue:3

    Topics: Amphipoda; Animals; Antidepressive Agents; Behavior, Animal; Carbamazepine; Diclofenac; Fluoxetine; Male; Serotonin; Swimming; Water Pollutants, Chemical

2010
Occurrence and loss over three years of 72 pharmaceuticals and personal care products from biosolids-soil mixtures in outdoor mesocosms.
    Water research, 2010, Volume: 44, Issue:20

    Topics: Antimitotic Agents; Azithromycin; Carbamazepine; Carbanilides; Ciprofloxacin; Diphenhydramine; Doxycycline; Environmental Monitoring; Fluoxetine; Sewage; Soil; Tetracycline; Thiabendazole; Triclosan

2010
Characterisation of zuclopenthixol metabolism by in vitro and therapeutic drug monitoring studies.
    Acta psychiatrica Scandinavica, 2010, Volume: 122, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Antifungal Agents; Antimalarials; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Clopenthixol; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Fluoxetine; Humans; In Vitro Techniques; Ketoconazole; Male; Methotrimeprazine; Microsomes, Liver; Middle Aged; Paroxetine; Quinidine

2010
Temporal resolution of solid-phase microextraction: measurement of real-time concentrations within a dynamic system.
    Analytical chemistry, 2010, Nov-15, Volume: 82, Issue:22

    Topics: Animals; Antidepressive Agents; Carbamazepine; Cattle; Feasibility Studies; Fluoxetine; Reproducibility of Results; Serum Albumin, Bovine; Solid Phase Microextraction; Time Factors

2010
Value of the small cohort study including a physical examination for minor structural defects in identifying new human teratogens.
    Congenital anomalies, 2011, Volume: 51, Issue:1

    Topics: Abnormalities, Drug-Induced; Anticonvulsants; Antidepressive Agents; Arthritis, Rheumatoid; Carbamazepine; Case-Control Studies; Cohort Studies; Female; Fever; Fluoxetine; Humans; Isoxazoles; Leflunomide; Maternal Exposure; Neural Tube Defects; Physical Examination; Pregnancy; Prospective Studies; Research Design; Teratogens; Tretinoin

2011
Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.
    Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2012, Volume: 155, Issue:1

    Topics: Animals; Behavior, Animal; Brain; Carbamazepine; Cyclohexanols; Cyprinidae; Female; Fluoxetine; Gene Expression Profiling; Gene Expression Regulation; Male; Oligonucleotide Array Sequence Analysis; Psychotropic Drugs; Reverse Transcriptase Polymerase Chain Reaction; Venlafaxine Hydrochloride

2012
Sampling-rate calibration for rapid and nonlethal monitoring of organic contaminants in fish muscle by solid-phase microextraction.
    Environmental science & technology, 2011, Sep-15, Volume: 45, Issue:18

    Topics: Animals; Atrazine; Calibration; Carbamazepine; Chromatography, High Pressure Liquid; Environmental Monitoring; Fluoxetine; Muscles; Oncorhynchus mykiss; Perches; Solid Phase Microextraction; Tandem Mass Spectrometry; Water Pollutants, Chemical

2011
Validation and use of in vivo solid phase micro-extraction (SPME) for the detection of emerging contaminants in fish.
    Chemosphere, 2011, Volume: 85, Issue:9

    Topics: Animals; Atrazine; Benzhydryl Compounds; Carbamazepine; Diclofenac; Environmental Monitoring; Fishes; Fluoxetine; Gemfibrozil; Ibuprofen; Naproxen; Phenols; Solid Phase Extraction; Solid Phase Microextraction; Waste Disposal, Fluid; Water Pollutants, Chemical

2011
Determination of pharmaceutical residues in fish bile by solid-phase microextraction couple with liquid chromatography-tandem mass spectrometry (LC/MS/MS).
    Environmental science & technology, 2012, May-15, Volume: 46, Issue:10

    Topics: Animals; Bile; Carbamazepine; Chromatography, Liquid; Cities; Cyprinidae; Drug Residues; Environmental Monitoring; Fluoxetine; Hydrolysis; Muscles; Oncorhynchus mykiss; Ontario; Solid Phase Microextraction; Tandem Mass Spectrometry; Waste Disposal, Fluid

2012
Psychoactive pharmaceuticals induce fish gene expression profiles associated with human idiopathic autism.
    PloS one, 2012, Volume: 7, Issue:6

    Topics: Animals; Autistic Disorder; Carbamazepine; Cell Adhesion Molecules; Cyclohexanols; Cyprinidae; Fluoxetine; Gene Expression Profiling; Gene Expression Regulation; Humans; Microarray Analysis; Nerve Tissue Proteins; Psychotropic Drugs; Receptors, Immunologic; Venlafaxine Hydrochloride; Water Pollutants, Chemical

2012
Direct rapid analysis of multiple PPCPs in municipal wastewater using ultrahigh performance liquid chromatography-tandem mass spectrometry without SPE pre-concentration.
    Analytica chimica acta, 2012, Aug-13, Volume: 738

    Topics: Acyclovir; Benzophenones; Carbamazepine; Chromatography, High Pressure Liquid; Fluconazole; Fluoxetine; Hong Kong; Metronidazole; Parabens; Pharmaceutical Preparations; Ranitidine; Sewage; Solid Phase Extraction; Sunscreening Agents; Tandem Mass Spectrometry

2012
Removal of trace organic chemical contaminants by a membrane bioreactor.
    Water science and technology : a journal of the International Association on Water Pollution Research, 2012, Volume: 66, Issue:9

    Topics: Amitriptyline; Bioreactors; Carbamazepine; Diazepam; Diclofenac; Fluoxetine; Gemfibrozil; Omeprazole; Organic Chemicals; Pharmaceutical Preparations; Sulfamethoxazole; Trimethoprim; Waste Disposal, Fluid; Water Pollutants, Chemical

2012
Oxcarbazepine and fluoxetine protect against mouse models of obsessive compulsive disorder through modulation of cortical serotonin and CREB pathway.
    Behavioural brain research, 2013, Jun-15, Volume: 247

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Carbamazepine; Cerebral Cortex; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Fluoxetine; Male; Mice; Obsessive-Compulsive Disorder; Oxcarbazepine; Selective Serotonin Reuptake Inhibitors; Serotonin; Signal Transduction

2013
Methylene blue used in the treatment of refractory shock resulting from drug poisoning.
    Clinical toxicology (Philadelphia, Pa.), 2014, Volume: 52, Issue:1

    Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antidotes; Antipsychotic Agents; Blood Gas Analysis; Blood Pressure; Carbamazepine; Dibenzothiazepines; Electrocardiography; Fluid Therapy; Fluoxetine; Humans; Hypnotics and Sedatives; Hypotension; Male; Methylene Blue; Oxazepam; Quetiapine Fumarate; Shock; Valproic Acid; Vasoconstrictor Agents

2014
Fate and uptake of pharmaceuticals in soil-earthworm systems.
    Environmental science & technology, 2014, May-20, Volume: 48, Issue:10

    Topics: Adsorption; Animals; Biodegradation, Environmental; Carbamazepine; Diclofenac; Fluoxetine; Lactones; Models, Biological; Oligochaeta; Orlistat; Pharmaceutical Preparations; Porosity; Quantitative Structure-Activity Relationship; Soil; Time Factors; Water

2014
Effects of short-term exposure to fluoxetine and carbamazepine to the collembolan Folsomia candida.
    Chemosphere, 2015, Volume: 120

    Topics: Animals; Arthropods; Carbamazepine; Cholinesterases; Ecotoxicology; Environmental Monitoring; Escape Reaction; Fluoxetine; Glutathione Transferase; Lipid Peroxidation; Soil Pollutants; Time Factors

2015
Modeling uptake of selected pharmaceuticals and personal care products into food crops from biosolids-amended soil.
    Environmental science & technology, 2014, Oct-07, Volume: 48, Issue:19

    Topics: Agriculture; Carbamazepine; Carbanilides; Cimetidine; Cosmetics; Crops, Agricultural; Diphenhydramine; Fluoxetine; Gemfibrozil; Miconazole; Models, Theoretical; Pharmaceutical Preparations; Plant Roots; Plant Shoots; Sewage; Soil Pollutants; Triclosan

2014
MicroQuEChERS-nanoliquid chromatography-nanospray-tandem mass spectrometry for the detection and quantification of trace pharmaceuticals in benthic invertebrates.
    Talanta, 2015, Volume: 132

    Topics: Animals; Anticonvulsants; Antidepressive Agents, Second-Generation; Carbamazepine; Chromatography, Liquid; Fluoxetine; Gastropoda; Liquid-Liquid Extraction; Species Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Water Pollutants, Chemical

2015
[Carbamazepine and psychotropic treatment interaction: Two case studies of carbamazepine overdosage].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2015, Volume: 22, Issue:5

    Topics: Adolescent; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Overdose; Drug Therapy, Combination; Female; Fluoxetine; Humans; Loxapine; Mental Disorders; Risperidone

2015
Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implications.
    Translational psychiatry, 2015, Jun-02, Volume: 5

    Topics: Animals; Anticonvulsants; Antidepressive Agents; Bone and Bones; Bone Density; Carbamazepine; Femur; Fluoxetine; Imipramine; Male; Rats; Rats, Sprague-Dawley; Valproic Acid; X-Ray Microtomography

2015
Low environmental levels of neuro-active pharmaceuticals alter phototactic behaviour and reproduction in Daphnia magna.
    Aquatic toxicology (Amsterdam, Netherlands), 2016, Volume: 170

    Topics: Animals; Behavior, Animal; Carbamazepine; Chromatography, High Pressure Liquid; Daphnia; Fluoxetine; Light; Propranolol; Reproduction; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Toxicity Tests; Water Pollutants, Chemical

2016
Derivation of water quality guidelines for priority pharmaceuticals.
    Environmental toxicology and chemistry, 2016, Volume: 35, Issue:7

    Topics: Animals; Aquatic Organisms; Carbamazepine; Diclofenac; Fluoxetine; Fresh Water; Guidelines as Topic; Pharmaceutical Preparations; Propranolol; Toxicity Tests, Chronic; Water Pollutants, Chemical; Water Quality

2016
Effects of soil properties on the uptake of pharmaceuticals into earthworms.
    Environmental pollution (Barking, Essex : 1987), 2016, Volume: 213

    Topics: Animals; Carbamazepine; Diclofenac; Fluoxetine; Hydrogen-Ion Concentration; Lactones; Oligochaeta; Orlistat; Pharmaceutical Preparations; Soil; Soil Pollutants; Water

2016
Maternal exposure to carbamazepine at environmental concentrations can cross intestinal and placental barriers.
    Biochemical and biophysical research communications, 2016, May-27, Volume: 474, Issue:2

    Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Female; Fluoxetine; Intestinal Absorption; Liver; Male; Maternal Exposure; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Placenta; Pregnancy; Psychotropic Drugs; Venlafaxine Hydrochloride; Water Pollutants, Chemical

2016
Psychoactive pharmaceuticals at environmental concentrations induce in vitro gene expression associated with neurological disorders.
    BMC genomics, 2016, 06-29, Volume: 17 Suppl 3

    Topics: Animals; Autistic Disorder; Carbamazepine; Cell Line, Tumor; Environmental Pollutants; Fluoxetine; Gene Expression Profiling; Humans; Nervous System Diseases; Neuroblastoma; Psychotropic Drugs; Transcriptome; Valproic Acid; Venlafaxine Hydrochloride

2016
A multi-omic approach to elucidate low-dose effects of xenobiotics in zebrafish (Danio rerio) larvae.
    Aquatic toxicology (Amsterdam, Netherlands), 2017, Volume: 182

    Topics: Acetaminophen; Animals; Carbamazepine; Diphenhydramine; Dose-Response Relationship, Drug; Fluoxetine; Larva; Metabolome; Models, Animal; Toxicity Tests; Transcriptome; Water Pollutants, Chemical; Xenobiotics; Zebrafish

2017
Dysregulation of autism-associated synaptic proteins by psychoactive pharmaceuticals at environmental concentrations.
    Neuroscience letters, 2017, Nov-20, Volume: 661

    Topics: Animals; Autism Spectrum Disorder; Autistic Disorder; Brain; Carbamazepine; Environment; Female; Fluoxetine; Gene Expression Profiling; Humans; Maternal Exposure; Nervous System Diseases; Venlafaxine Hydrochloride

2017
Effects of low concentrations of psychiatric drugs (carbamazepine and fluoxetine) on the freshwater planarian, Schmidtea mediterranea.
    Chemosphere, 2019, Volume: 217

    Topics: Animals; Antidepressive Agents, Second-Generation; Carbamazepine; Fluoxetine; Fresh Water; Planarians

2019
Pharmacological evaluation of NO/cGMP/KATP channels pathway in the antidepressant-like effect of carbamazepine in mice.
    Behavioural pharmacology, 2021, 02-01, Volume: 32, Issue:1

    Topics: Animals; Anticonvulsants; Antidepressive Agents; Carbamazepine; Cyclic GMP; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; KATP Channels; Locomotion; Male; Mice; Nitric Oxide; Swimming

2021
Susceptibility of Folsomia candida to Agrochemicals after Multigenerational Exposure to Human Pharmaceuticals.
    Environmental toxicology and chemistry, 2022, Volume: 41, Issue:3

    Topics: Agrochemicals; Animals; Arthropods; Carbamazepine; Copper; Dimethoate; Fluoxetine; Humans; Pharmaceutical Preparations; Reproduction; Soil; Soil Pollutants

2022
Effects of central nervous system drugs on androgen, estrogen α, glucocorticoid, and thyroid receptors.
    Chemico-biological interactions, 2022, Aug-25, Volume: 363

    Topics: Androgens; Animals; Carbamazepine; Central Nervous System Agents; CHO Cells; Clonazepam; Cricetinae; Cricetulus; Estrogen Receptor alpha; Estrogens; Fluoxetine; Glucocorticoids; Luciferases, Firefly; Paroxetine; Receptors, Androgen; Receptors, Glucocorticoid; Sertraline; Thyroid Gland

2022
Influence of exposure time, physicochemical properties, and plant transpiration on the uptake dynamics and translocation of pharmaceutical and personal care products in the aquatic macrophyte Typha latifolia.
    The Science of the total environment, 2023, Oct-20, Volume: 896

    Topics: Carbamazepine; Chromatography, Liquid; Cosmetics; Fluoxetine; Gemfibrozil; Pharmaceutical Preparations; Plant Transpiration; Tandem Mass Spectrometry; Triclosan; Typhaceae; Water Pollutants, Chemical

2023